Sandbox skin2: Difference between revisions

Jump to navigation Jump to search
Gerald Chi- (talk | contribs)
Gerald Chi- (talk | contribs)
Line 32: Line 32:


* Impetigo, adult
* Impetigo, adult
:* Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic streptococci)
::* '''Limited number of lesions'''
:::* Preferred regimen: [[Mupirocin]] topically bid for 5 days {{or}} [[Retapamulin]] topically bid for 5 days
::* '''Numerous lesions or outbreaks of post streptococcal glomerulonephritis'''
:::* Preferred regimen: [[Dicloxacillin]] 250 mg PO qid for 7 days {{or}} [[Amoxicillin-Clavulanate]] 875/125 mg PO bid for 7 days {{or}} [[Cephalexin]] 250 mg PO qid for 7 days
:::* Alternative regimen (for penicillin-allergic patients): [[Doxycycline]] 100 mg PO bid for 7 days {{or}} [[Clindamycin]] 300–400 mg PO qid for 7 days {{or}} [[Sulfamethoxazole-Trimethoprim]] 1–2 double-strength tablets PO bid for 7 days
:* Culture-directed antimicrobial therapy
::* '''Streptococcus alone'''
:::* Preferred regimen: [[Penicillin V]] 250–500 mg PO qid for 7 days
:::* Alternative regimen (for penicillin-allergic patients): [[Erythromycin]] 250 mg PO qid for 7 days {{or}} [[Clindamycin]] 300–400 mg PO qid for 7 days
::* '''Methicillin-resistant Staphylococcus aureus'''
:::* Preferred regimen: [[Doxycycline]] 100 mg PO bid for 7 days {{or}} [[Clindamycin]] 300–450 mg PO qid for 7 days {{or}} [[Sulfamethoxazole-Trimethoprim]] 1–2 double-strength tablets PO bid for 7 days
* Impetigo, pediatric
:* Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic streptococci)
:* Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic streptococci)
::* '''Limited number of lesions'''
::* '''Limited number of lesions'''

Revision as of 02:31, 30 May 2015

Acne vulgaris

Acne rosacea

Anthrax, cutaneous

Bacillary angiomatosis

Bite wounds

Carbuncle

Cat scratch disease

Cellulitis

Ecthyma

Erysipelas

Erysipeloid

Erythrasma

Furuncle

Gas gangrene

Glanders

Impetigo

  • Impetigo, adult
  • Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic streptococci)
  • Limited number of lesions
  • Numerous lesions or outbreaks of post streptococcal glomerulonephritis
  • Culture-directed antimicrobial therapy
  • Streptococcus alone
  • Preferred regimen: Penicillin V 250–500 mg PO qid for 7 days
  • Alternative regimen (for penicillin-allergic patients): Erythromycin 250 mg PO qid for 7 days OR Clindamycin 300–400 mg PO qid for 7 days
  • Methicillin-resistant Staphylococcus aureus
  • Impetigo, pediatric
  • Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic streptococci)
  • Limited number of lesions
  • Numerous lesions or outbreaks of post streptococcal glomerulonephritis
  • Culture-directed antimicrobial therapy
  • Streptococcus alone
  • Preferred regimen: Penicillin V 250–500 mg PO qid for 7 days
  • Alternative regimen (for penicillin-allergic patients): Erythromycin 250 mg PO qid for 7 days OR Clindamycin 300–400 mg PO qid for 7 days
  • Methicillin-resistant Staphylococcus aureus

Lyme disease, cutaneous

Mastitis

Necrotizing fasciitis

Pilonidal cyst

Pyomyositis

Seborrheic dermatitis

Surgical site infections

Vascular insufficieny ulcer

Vibrio infection

Wound infection

Yaws